PROGNOSTIC FACTORS IN NONSMALL CELL LUNG-CANCER

被引：27

作者：

FELD, R

BORGES, M

GINER, V

GINSBERG, R

HARPER, P

KLASTERSKY, J

LACQUET, L

PAESMANS, M

PAYNE, D

ROSELL, R

SAUSE, W

SCULIER, JP

SHAW, E

SORENSEN, JB

SPLINTER, T

STAHEL, R

BUNN, P

机构：

[1] HOSP SANTA MARIA,SERV PNEUMOL,LISBON,PORTUGAL

[2] HOSP DR PESET,UNIDAD ONCOL MED,VALENCIA,SPAIN

[3] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY

[4] GUYS HOSP,LONDON,ENGLAND

[5] INST JULES BORDET,BRUSSELS,BELGIUM

[6] UNIV NIJMEGEN ST RADBOUD HOSP,NIJMEGEN,NETHERLANDS

[7] HOSP BARCELONA GERMANS TRIAS & PUJOL,BARCELONA,SPAIN

[8] LATTER DAY ST HOSP,CTR RADIAT,SALT LAKE CITY,UT

[9] MAYO CLIN & MAYO FDN,ROCHESTER,MN

[10] RIGSHOSP,DEPT ONCOL,DK-2100 COPENHAGEN,DENMARK

[11] UNIV ROTTERDAM HOSP,ROTTERDAM,NETHERLANDS

[12] UNIV ZURICH,ZURICH,SWITZERLAND

[13] UNIV COLORADO,DENVER,CO

来源：

LUNG CANCER | 1994年 / 11卷

关键词：

D O I：

10.1016/0169-5002(94)91861-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：S19 / S23

页数：5

共 50 条

[1] SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].

ALBAIN, KS ;

CROWLEY, JJ ;

LEBLANC, M ;

LIVINGSTON, RB .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626

[2] ANALYSIS OF SURVIVAL BY TUMOR RESPONSE [J].

ANDERSON, JR ;

CAIN, KC ;

GELBER, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :710-719

[3] CLINICAL CHARACTERIZATION OF NON-SMALL-CELL LUNG-CANCER TUMORS SHOWING NEURO-ENDOCRINE DIFFERENTIATION FEATURES [J].

BERENDSEN, HH ;

DELEIJ, L ;

POPPEMA, S ;

POSTMUS, PE ;

BOES, A ;

SLUITER, HJ ;

THE, H .

JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1614-1620

[4]

CAIL MH, 1984, CANCER, V54, P1802

[5]

CARNEY D N, 1991, Current Opinion in Oncology, V3, P288, DOI 10.1097/00001622-199104000-00009

[6] PROGNOSTIC FACTORS FROM A RANDOMIZED CLINICAL-TRIAL IN RESECTED LUNG-CANCER [J].

CHASTANG, C ;

LEBEAU, B ;

CHARPAK, Y ;

DECROIX, G .

STATISTICS IN MEDICINE, 1985, 4 (03) :279-285

[7]

DESLAURIERS J, 1989, J THORAC CARDIOV SUR, V97, P504

[8] RANDOM PROSPECTIVE-STUDY OF VINDESINE VERSUS VINDESINE PLUS HIGH-DOSE CISPLATIN VERSUS VINDESINE PLUS CISPLATIN PLUS MITOMYCIN-C IN ADVANCED NON-SMALL-CELL LUNG-CANCER [J].

EINHORN, LH ;

LOEHRER, PJ ;

WILLIAMS, SD ;

MEYERS, S ;

GABRYS, T ;

NATTAN, SR ;

WOODBURN, R ;

DRASGA, R ;

SONGER, J ;

FISHER, W ;

STEPHENS, D ;

HUI, S .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (07) :1037-1043

[9] A RANDOMIZED STUDY OF ORAL NUTRITIONAL SUPPORT VERSUS AD-LIB NUTRITIONAL INTAKE DURING CHEMOTHERAPY FOR ADVANCED COLORECTAL AND NON-SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

NIXON, DW ;

DALY, JM ;

ELLENBERG, SS ;

GARDNER, L ;

WOLFE, E ;

SHEPHERD, FA ;

FELD, R ;

GRALLA, R ;

FINE, S ;

KEMENY, N ;

JEEJEEBHOY, KN ;

HEYMSFIELD, S ;

HOFFMAN, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (01) :113-124

[10]

Feld R, 1991, LUNG CANCER, V7, P3

← 1 2 3 4 5 →